First FDA-approved stent designed specifically for the smallest patients with certain congenital heart and vascular conditions.LONG BEACH, Calif., Sept. 14, 2026 /PRNewswire/ -- The Children's Heart Institute at Miller Children's & Women's Hospital has successfully performed the Renata Minima Stent procedure in two…
Locally owned wellness destination will offer private infrared sauna and red light therapy, with Founding Member rates available ahead of its mid-September opening.HOUSTON, Sept. 9, 2026 /PRNewswire/ -- For Clyde and Denia Smith, wellness is more than a…
Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes through…
Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia.SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- On September 7, 2026, Shanghai, Cell…
-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection ---- Robust neutralizing antibody responses across…
SHANGHAI, Sept. 6, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up…
The association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with clarity, confidence, and authenticity without sacrificing themselves in the processBOSTON, Aug. 29, 2026 /PRNewswire/ -- The…
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ -- Pharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on advancing pharmacists' integration into primary health care, where they identified workforce readiness, sustainable funding models, supportive…
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate AHB-171 and next-generation combination approaches designed to advance functional cure for chronic hepatitis BSeries C brings AusperBio's total…
SHANGHAI and HONG KONG, Aug. 24, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies,…